診療科・部門紹介
診療科・部門紹介

食道外科

食道外科

最終更新日 : 2018年3月22日

診療科の特徴診療実績スタッフ紹介|トピックス

【2014】

  1. Watanabe M, Mine S, Yamada K, Shigaki H, Baba Y, Yoshida N, Kajiyama K, Yamamoto N, Sano T, Baba H:
    Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.
    Gen Thorac Cardiovasc Surg 62(11):685-92, 2014.
  2. 渡邊雅之, 志垣博信, 松本晶, 西田康二郎, 峯真司:
    食道癌の疫学と発癌リスク
    Pharma Medica 32(7):9-12, 2014.
  3. 渡邊雅之, 吉田直矢, 馬場祥史, 井田智, 馬場秀夫:
    頸部食道癌に対する集学的治療戦略.
    日本気管食道科学会会報 65(2):142-3, 2014.

【2015】

  1. Mine S, Nunobe S, Watanabe M:
    A novel technique of anti-reflux esophagogastrostomy following left thoracoabdominal esophagectomy for carcinoma of the esophagogastric junction.
    World J Surg 39(9): 2359-2361, 2015.
  2. Saeki H, Watanabe M, Mine S, Shigaki H, Oya S, Ishiyama A, Tsuchida T, Fujisaki J, Baba H, Maehara Y, Sano T:
    Esophagectomy for superficial esophageal cancer after non-curative endoscopic resection.
    J Gastroenterol 50(4): 406-413, 2015.
  3. Watanabe M, Mine S, Nishida K, Yamada K, Shigaki H, Matsumoto A, Sano T:
    Salvage esophagectomy after definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: Who really benefits from this high-risk surgery?
    Ann Surg Oncol22(13): 4438-4444, 2015.
  4. Watanabe M:
    Risk factors and molecular mechanisms of esophageal cancer: differences between the histologic subtypes.
    J Cancer Metastasis Treat 1: 1-7, 2015.
  5. Hiyoshi Y, Watanabe M:
    MicroRNAs in gastrointestinal cancer: a novel biomarker and its clinical application.
    J Cancer Metastasis Treat 3: 144-155, 2015.
  6. Imamura Y, Tokunaga R, Nakamura K, Baba H, Watanabe M:
    Overview of genetic alterations in the pathogenesis of esophagogastric junctional adenocarcinoma and esophageal adenocarcinoma: recent findings by next generation sequencing.
    J Cancer Metastasis Treat3: 123-129, 2015.
  7. Ida S, Watanabe M, Baba H:
    Chronic inflammation and gastrointestinal cancer.
    J Cancer Metastasis Treat 3: 138-143, 2015.
  8. Eto K, Watanabe M:
    Trends in clinical use of targeted therapy for gastrointestinal cancers. J Cancer Metastasis Treat 3: 163-171, 2015.
  9. Shigaki H, Baba Y, Harada K, Yoshida N, Watanabe M, Baba H:
    Epigenetics in GI cancer.
    J Cancer Metastasis Treat 3: 113-122, 2015.
  10. Matsumoto A, Watanabe M, Shigaki H, Okumura Y, Nishida K, Mine S, Yamada K, Yanaga K, Sano T:
    Intussusception causing postoperative intestinal obstruction following free jejunal transfer in adults: two case reports and review of the literature.
    Surg Case Rep 1: 28, 2015.
  11. Oya S, Mine S, Watanabe M, Yamada K:
    Oesophageal cancer with an aberrant right subclavian artery accompanied by a thoracic duct anomaly.
    Eur J Cardiothorac Surg 48(3): e55-57, 2015.
  12. Watanabe M:
    Editorial: Introduction to volume 1 issue 3 of Journal of Cancer Metastasis and Treatment.
    J Cancer Metastasis Treat 1(3): 111-112, 2015.
  13. 渡邊雅之:
    消化器外科のドレーン看護.
    消化器外科NURSING 2015春季増刊号 84-87, 2015.
  14. 渡邊雅之、黒河内喬範、岡村明彦、今村裕、本多通孝、西田康二郎、峯真司:
    食道外科における消化管吻合のコツ‐器械吻合.
    臨床外科 70(10): 1211-1216, 2015.

【2016】

  1. Matsumoto A, Watanabe M, Shigaki H, Nishida K, Mine S, Sano T, Yanaga K:
    Efficacy of staged treatment strategy for patients with synchronous double cancers of the esophagus and head and neck: a retrospective study.
    World J Surg 40(2): 388-394, 2016.
  2. Mine S, Watanabe M:
    A commentary on 'Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia'.
    Transl Gastroenterol Hepatol 1: 12, 2016.
  3. Okamura A, Watanabe M, Kurogochi T, Imamura Y, Nishida K, Mine S: Mediastinal Adiposity Influences the Technical Difficulty of Thoracic Procedure in Minimally Invasive Esophagectomy.
    World J Surg 40(10): 2398-2404, 2016.
  4. Okamura A, Watanabe M, Mine S, Nishida K, Imamura Y, Kurogochi T, Sano T:
    Factors influencing difficulty of the thoracic procedure in minimally invasive esophagectomy.
    Surg Endosc 30(10): 4279-4285, 2016.
  5. Okamura A, Watanabe M, Mine S, Nishida K, Imamura Y, Kurogochi T, Kitagawa Y, Sano T:
    Clinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma.
    Ann Surg Oncol 23(4): 1387-1394, 2016.
  6. Okamura A, Watanabe M, Mine S, Nishida K, Kurogochi T, Imamura Y: Spirometric lung age predicts postoperative pneumonia after esophagectomy.
    World J Surg 40(10): 2412-2418, 2016.
  7. Watanabe M, Mine S, Nishida K, Yamada K, Shigaki H, Oya S, Matsumoto A, Kurogochi T, Okamura A, Imamura Y, Sano T:
    Improvement in short-term outcomes after esophagectomy with a multidisciplinary perioperative care team.
    Esophagus 13(4): 337-342, 2016.
  8. Watanabe M, Mine S, Nishida K, Kurogochi T, Okamura A, Imamura Y: Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy.
    Gen Thorac Cardiovasc Surg 64(8): 457-463, 2016.
  9. 渡邊雅之:
    食道癌の術後障害とその対策.
    日本気管食道科学会専門医通信 52: 12-18, 2016.
  10. 渡邊雅之、志垣博信、松本晶、西田康二郎、峯真司、佐野武、山口俊晴:
    食道癌の治療方針決定に必要な画像診断.
    コンセンサス癌治療 14(1): 2-7, 2016.
  11. 渡邊雅之、藤井亜砂美:
    食道亜全摘・3領域リンパ節郭清・胃管再建(頸部食道胃管吻合)のドレーン.
    消化器外科NURSING. 21 (6): 58, 2016.
  12. 渡邊雅之、藤井亜砂美:
    中下部食道切除・2領域リンパ節郭清・胃管再建(胸腔内食道胃管吻合)のドレーン.
    消化器外科NURSING. 21 (6): 59, 2016.
  13. 峯真司、渡邊雅之、新橋渉:
    イラストで学ぶ消化器外科再建法のすべて.食道.空腸再建 遊離空腸再建.
    外科 78(12): 1294-1297, 2016.

【2017】

  1. Mine S, Watanabe M, Imamura Y, Okamura A, Kurogochi T, Sano T:
    Clinical significance of the pre-therapeutic nodal size in patients undergoing neo-adjuvant treatment followed by esophagectomy for esophageal squamous cell carcinoma.
    World J Surg 41(1): 184-190, 2017.
  2. Okamura A, Watanabe M, Imamura Y, Kamiya S, Yamashita K, Kurogochi T, Mine S:
    Preoperative glycosylated hemoglobin levels predict the anastomotic leak after esophagectomy with cervical esophagogastric anastomosis. World J Surg 41(2): 200-207, 2017.
  3. Matsumoto A, Watanabe M, Mine S, Nishida K, Shigaki H, Kawabata K, Yanaga K, Sano T:
    Comparison of synchronous versus staged surgeries for patients with synchronous double cancers of the esophagus and head-and-neck.
    Dis Esophagus 30(1): 1-6, 2017.
  4. Hayami M, Hiki N, Nunobe S, Mine S, Ohashi M, Kumagai K, Ida S, Watanabe M, Sano T, Yamaguchi T:
    Clinical outcomes and evaluation of laparoscopic proximal gastrectomy with double^flap technique for early gastric cancer in the upper third of the stomach.
    Ann Surg Oncol 24(6): 1635-1642, 2017.
  5. Yamashita K, Watanabe M, Mine S, Kurogochi T, Okamura A, Hayami M, Imamura Y:
    Patterns and outcomes of recurrent esophageal cancer after curative esophagectomy.
    World J Surg 41(9): 2337-2344, 2017.
  6. Okamura A, Watanabe M, Imamura Y, Hayami M, Yamashita K, Kurogochi T, Mine S:
    Glycemic status and prognosis of patients with squamous cell carcinoma of the esophagus.
    World J Surg 41(10): 2591-2597, 2017.
  7. Mine S, Watanabe M, Okamura A, Imamura Y, Kajiyama Y, Sano T:  Superior thoracic aperture size is significantly associated with cervical anastomotic leakage after esophagectomy.
    World J Surg 41(10): 2598-2604, 2017.
  8. Shigaki H, Imamura Y, Mine S, Okamura A, Kurogochi T, Yamashita K, Watanabe M:
    Clinicopathologic features of esophageal squamous cell carcinoma in never smoker-never drinkers.
    Dis Esophagus 30(5): 1-7, 2017.
  9. Okamura A, Watanabe M, Mine S, Kurogochi T, Yamashita K, Hayami M, Imamura Y, Ogura M, Ichimura T, Takahari D, Chin K:
    Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Dis Esophagus 30(9): 1-8, 2017.
  10. Okamura A, Watanabe M, Imamura Y, Hayami M, Yuda M, Yamashita K, Shoji Y, Mine S:
    Cervicothoracoscopic approach in esophagectomy.
    Ann Surg Oncol 25(1): 333, 2017.
  11. Hayami M, Watanabe M, Ishizuka N, Nine S, Imamura Y, Okamura A, Kurogochi T, Yamashita K:
    Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy.
    J Surg Oncol. doi: 10.1002/jso.24941, 2017.
  12. Okamura A, Watanabe M, Yamashita K, Yuda M, Hayami M, Imamura Y, Mine S:
    Implication of visceral obesity in patients with esophageal squamous cell carcinoma.
    Langenbeck Arch Surg doi: 10.1007/s00423-017-1643-0, 2017.
  13. Watanabe M:
    Editorial: Transcription factor SPZ1 may promote TWIST-mediated epithelial-mesenchymal transition in thoracic malignancies.
    J Thorac Dis 9(9): 2740-2742, 2017.
  14. Kurogochi T, Mine S, Kawachi H:
    Anti-neutrophil cytoplasmic antibody-associated vasculitis resembling esophageal cancer. Dig Endosc 2017; 29: 236-237.
  15. 峯真司、渡邊雅之:
    食道癌外科治療のすべて:食道癌の治療方針および手術適応の評価.
    外科79 (4): 301-304, 2017.
  16. 岡村明彦、渡邊雅之、今村裕、神谷諭、速水克、山下公太郎、黒河内喬範、峯真司:
    反回神経麻痺の診断と治療. 胸腔鏡下食道切除術後反回神経麻痺の現状と術後肺炎予防における周術期管理チームの意義.
    日本気管食道科学会誌. 68(2): 189-191, 2017
  17. 岡村明彦、渡邊雅之:
    特集:胸部外科領域における合併症予防のための周術期管理 食道癌周術期管理におけるチーム医療. 胸部外科 70 (8): 712-715, 2017.
  18. 渡邊雅之、山下公太郎、湯田匡己、速水克、岡村明彦、今村裕、峯真司:
    特集/わかりやすい消化管癌診療のコンセンサス.食道癌.胸腔鏡手術.臨床と研究 94(12): 1479-1483, 2017.
  19. 梅野博仁、渡邊雅之:
    ワークショップ3反回神経麻痺の診断と治療 司会者のまとめ. 
    日本気管食道科学会誌68 (2) 185-186, 2017.

このページのTOPへ